Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids

G Henriksson, T Norlander, X Zheng… - American journal of …, 1997 - journals.sagepub.com
G Henriksson, T Norlander, X Zheng, P Stierna, KM Westrin
American journal of rhinology, 1997journals.sagepub.com
The synthesis of P-glycoprotein 170 (P-gp), a “multidrug resistance” protein capable of
extruding various drugs including 11-OH steroids from human cells, can be upregulated by
certain glucocorticosteroids. This study demonstrates the presence of P-gp in the columnar
surface epithelium and in glandular acini of healthy nasal mucosa with
immunohistochemical technique. Furthermore, nasal polyps from 5 of 17 patients treated
with clinical doses of a topical nasal steroid, budesonide, appear to show a stronger staining …
The synthesis of P-glycoprotein 170 (P-gp), a “multidrug resistance” protein capable of extruding various drugs including 11-OH steroids from human cells, can be upregulated by certain glucocorticosteroids. This study demonstrates the presence of P-gp in the columnar surface epithelium and in glandular acini of healthy nasal mucosa with immunohistochemical technique. Furthermore, nasal polyps from 5 of 17 patients treated with clinical doses of a topical nasal steroid, budesonide, appear to show a stronger staining intensity for P-gp than polyps from 13 untreated patients. This suggests the possibility of local P-gp gene induction by topical glucocorticoid treatment. Upregulation of P-gp synthesis appears as a new possible cause of relative resistance to topical steroid medication in patients with nasal inflammatory disease.
Sage Journals